In a significant leap for the field of photonics, an international team of researchers has successfully demonstrated the creation of…
Read More
Regulatory round-up: Novartis, Sanofi and Arrowhead secure CHMP blessings – Pharmaceutical Technology
The European Committee for Medicinal Products for Human Use (CHMP) has issued positive opinions on three promising new drug candidates,…
Read More
Science News: Empowering Public Understanding of Science Since 1921
Since its inception in 1921, Science News has been a steadfast beacon of accurate and accessible information, dedicated to illuminating…
Read More
Earth’s Ancient Giants: New Study Challenges Oxygen Theory Behind Prehistoric Insect Colossi
Three hundred million years ago, Earth was a planet vastly different from the one we inhabit today. Its landmasses were…
Read More
Johns Hopkins Study Reveals How Liquid Droplets Formed by Fusion Genes Drive Rare Kidney Cancer Progression
In a significant advancement for molecular oncology, investigators at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins Bloomberg…
Read More
Ensuring Monoclonality in Cell Cloning: Sartorius’s CellCelector Nanowell Technology Revolutionizes Biopharmaceutical Development
Ensuring monoclonality in cell cloning processes is a critical challenge in the biotechnology and pharmaceutical industries, where cell purity and…
Read More
Pharma 50: The 50 Best-Selling Drugs of FY2025
The fiscal year 2025 concluded with a dramatic reshaping of the pharmaceutical industry’s top echelons, marked by intense competition at…
Read More
Gut Bacteria Sugars Identified as Potential Trigger for ALS and Frontotemporal Dementia in Breakthrough Case Western Reserve University Study
Researchers at Case Western Reserve University have unveiled a landmark discovery that identifies a specific molecular link between the human…
Read More
Walk-In Lab Testing Expands Patient Access and Autonomy in West Virginia
The landscape of healthcare diagnostics is undergoing a profound transformation, with West Virginia emerging as a key example of a…
Read More
Biogen Secures Global Rights to TJ Biopharma’s Felzartamab in Landmark $850 Million Deal, Aiming to Disrupt Multiple Myeloma Treatment Landscape
Biogen announced on April 20, 2026, a significant strategic acquisition, securing exclusive rights to TJ Biopharma’s novel anti-CD38 immunotherapy, felzartamab,…
Read More
